Cocrystal Pharma Files 10Q Quarterly Report Highlighting Clinical Pipeline Progress HubSpot HUBS Reports Strong Q1 2026 Revenue NA EPS Beats Soaring Oil Prices Threaten Higher European Air Fares Industry Body Warns X4 Pharmaceuticals XFOR Q1 2026 Earnings Why the Beat Matters Filana Therapeutics FLNA Gains 638 as Biotech Momentum Builds FGI Industries FGI Faces Slight Decline as Stock Hovers Near Support Zone BristolMyers Squibb BMY Sees Modest Decline Holds Above Key Support ENJ Bonds Edge Higher as Entergy New Orleans 50 Series Approaches Resistance Steady Demand in FixedIncome Market